Expanding Naloxone Access Needs Normalizing First-Aid Use, Keeping Purchase Records Private
Opposition to making naloxone available OTC remains strident because of stigma surrounding drug overdoses, says Bobby Mukkamala, a head and neck surgeon and an AMA Board of Trustees member.
